Adage Capital Partners GP L.L.C. Boosts Stock Holdings in LifeStance Health Group, Inc. $LFST

Adage Capital Partners GP L.L.C. grew its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 43.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,000 shares of the company's stock after purchasing an additional 70,000 shares during the quarter. Adage Capital Partners GP L.L.C. owned approximately 0.06% of LifeStance Health Group worth $1,532,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of LifeStance Health Group by 5.0% during the 1st quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company's stock valued at $74,733,000 after purchasing an additional 531,841 shares in the last quarter. Jennison Associates LLC increased its holdings in LifeStance Health Group by 2.1% in the 1st quarter. Jennison Associates LLC now owns 8,255,236 shares of the company's stock worth $54,980,000 after acquiring an additional 168,856 shares in the last quarter. Wellington Management Group LLP increased its holdings in LifeStance Health Group by 2.3% in the 1st quarter. Wellington Management Group LLP now owns 5,399,293 shares of the company's stock worth $35,959,000 after acquiring an additional 123,056 shares in the last quarter. Parcion Private Wealth LLC purchased a new stake in LifeStance Health Group in the 1st quarter worth $15,670,000. Finally, Northern Trust Corp increased its holdings in LifeStance Health Group by 11.7% in the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company's stock worth $11,731,000 after acquiring an additional 166,731 shares in the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Trading Up 4.5%

Shares of LFST opened at $5.61 on Tuesday. LifeStance Health Group, Inc. has a 52-week low of $3.74 and a 52-week high of $8.61. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.19. The firm's fifty day moving average is $4.77 and its two-hundred day moving average is $5.79. The stock has a market cap of $2.18 billion, a PE ratio of -112.20 and a beta of 1.17.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.02. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The company had revenue of $345.31 million for the quarter, compared to analysts' expectations of $345.05 million. During the same quarter in the previous year, the company posted ($0.06) EPS. The firm's quarterly revenue was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Research analysts forecast that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on LFST. Wall Street Zen raised shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. BTIG Research began coverage on shares of LifeStance Health Group in a report on Friday, July 25th. They issued a "buy" rating and a $8.00 price target for the company. Finally, UBS Group boosted their price target on shares of LifeStance Health Group from $8.50 to $9.00 and gave the stock a "buy" rating in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $8.50.

Insiders Place Their Bets

In other LifeStance Health Group news, major shareholder Summit Partners L. P sold 8,407,643 shares of LifeStance Health Group stock in a transaction on Monday, August 18th. The shares were sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the sale, the insider owned 33,524,715 shares of the company's stock, valued at $169,970,305.05. The trade was a 20.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Darren M. Black sold 8,407,643 shares of LifeStance Health Group stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the sale, the director directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 20,407,643 shares of company stock valued at $103,466,750 in the last 90 days. 6.60% of the stock is owned by insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.